150 related articles for article (PubMed ID: 14642017)
1. Quetiapine treatment of children and adolescents with Tourette's disorder.
Mukaddes NM; Abali O
J Child Adolesc Psychopharmacol; 2003; 13(3):295-9. PubMed ID: 14642017
[TBL] [Abstract][Full Text] [Related]
2. Quetiapine treatment of children with Tourette's syndrome: report of two cases.
Párraga HC; Párraga MI; Woodward RL; Fenning PA
J Child Adolesc Psychopharmacol; 2001; 11(2):187-91. PubMed ID: 11436959
[TBL] [Abstract][Full Text] [Related]
3. Clinical effectiveness of quetiapine in children and adolescents with Tourette's syndrome : a retrospective case-note survey.
Copur M; Arpaci B; Demir T; Narin H
Clin Drug Investig; 2007; 27(2):123-30. PubMed ID: 17217317
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China.
Cui YH; Zheng Y; Yang YP; Liu J; Li J
J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):291-8. PubMed ID: 20807067
[TBL] [Abstract][Full Text] [Related]
5. Quetiapine in patients with Tourette's disorder: an open-label, flexible-dose study.
de Jonge JL; Cath DC; van Balkom AJ
J Clin Psychiatry; 2007 Jul; 68(7):1148-50. PubMed ID: 17685760
[No Abstract] [Full Text] [Related]
6. Effectiveness and safety of risperidone for children and adolescents with chronic tic or tourette disorders in Korea.
Kim BN; Lee CB; Hwang JW; Shin MS; Cho SC
J Child Adolesc Psychopharmacol; 2005 Apr; 15(2):318-24. PubMed ID: 15910216
[TBL] [Abstract][Full Text] [Related]
7. Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: an open-label extension trial.
McConville B; Carrero L; Sweitzer D; Potter L; Chaney R; Foster K; Sorter M; Friedman L; Browne K
J Child Adolesc Psychopharmacol; 2003; 13(1):75-82. PubMed ID: 12804128
[TBL] [Abstract][Full Text] [Related]
8. Open-label quetiapine in the treatment of children and adolescents with autistic disorder.
Martin A; Koenig K; Scahill L; Bregman J
J Child Adolesc Psychopharmacol; 1999; 9(2):99-107. PubMed ID: 10461820
[TBL] [Abstract][Full Text] [Related]
9. A prospective 12-week study of quetiapine in adolescents with schizophrenia spectrum disorders.
Schimmelmann BG; Mehler-Wex C; Lambert M; Schulze-zur-Wiesch C; Koch E; Flechtner HH; Gierow B; Maier J; Meyer E; Schulte-Markwort M
J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):768-78. PubMed ID: 18315449
[TBL] [Abstract][Full Text] [Related]
10. [Quetiapine in the treatment of the Gilles de la Tourette syndrome. A case study].
Neves Ramos D; van West D; van Strien AP
Tijdschr Psychiatr; 2007; 49(4):263-7. PubMed ID: 17436213
[TBL] [Abstract][Full Text] [Related]
11. Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report.
Lombroso PJ; Scahill L; King RA; Lynch KA; Chappell PB; Peterson BS; McDougle CJ; Leckman JF
J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1147-52. PubMed ID: 7559308
[TBL] [Abstract][Full Text] [Related]
12. Tolerability of quetiapine in children and adolescents with Tourette's syndrome.
Copur M; Hergüner S; Arpaci B
Int J Clin Pharmacol Ther; 2011 Feb; 49(2):177-8. PubMed ID: 21255535
[No Abstract] [Full Text] [Related]
13. Olanzapine in the treatment of aggression and tics in children with Tourette's syndrome--a pilot study.
Stephens RJ; Bassel C; Sandor P
J Child Adolesc Psychopharmacol; 2004; 14(2):255-66. PubMed ID: 15319022
[TBL] [Abstract][Full Text] [Related]
14. Quetiapine in nine youths with autistic disorder.
Findling RL; McNamara NK; Gracious BL; O'Riordan MA; Reed MD; Demeter C; Blumer JL
J Child Adolesc Psychopharmacol; 2004; 14(2):287-94. PubMed ID: 15319025
[TBL] [Abstract][Full Text] [Related]
15. A study of quetiapine: efficacy and tolerability in psychotic adolescents.
Shaw JA; Lewis JE; Pascal S; Sharma RK; Rodriguez RA; Guillen R; Pupo-Guillen M
J Child Adolesc Psychopharmacol; 2001; 11(4):415-24. PubMed ID: 11838824
[TBL] [Abstract][Full Text] [Related]
16. Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study.
Lyon GJ; Samar S; Jummani R; Hirsch S; Spirgel A; Goldman R; Coffey BJ
J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):623-33. PubMed ID: 20035580
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled pilot study of quetiapine in the treatment of adolescent conduct disorder.
Connor DF; McLaughlin TJ; Jeffers-Terry M
J Child Adolesc Psychopharmacol; 2008 Apr; 18(2):140-56. PubMed ID: 18439112
[TBL] [Abstract][Full Text] [Related]
18. An open-label study of the treatment efficacy of olanzapine for Tourette's disorder.
Budman CL; Gayer A; Lesser M; Shi Q; Bruun RD
J Clin Psychiatry; 2001 Apr; 62(4):290-4. PubMed ID: 11379844
[TBL] [Abstract][Full Text] [Related]
19. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study.
Sallee FR; Kurlan R; Goetz CG; Singer H; Scahill L; Law G; Dittman VM; Chappell PB
J Am Acad Child Adolesc Psychiatry; 2000 Mar; 39(3):292-9. PubMed ID: 10714048
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and tolerability of open label olanzapine in children and adolescents with Tourette syndrome.
McCracken JT; Suddath R; Chang S; Thakur S; Piacentini J
J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):501-8. PubMed ID: 18928414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
